Floatz logo

Autologous Immunoglobulin Idiotype-Klh Conjugate Vaccine

Central Nervous System Neoplasm

University of Texas Southwestern Medical CentervaccinePhase 2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
95/ 100

Competitive context

48 Active assets in the Central Nervous System Neoplasm cohort.

Asset / SponsorPhaseRating
Procarbazine
Universitätsmedizin Mannheim
Phase 3BBB
VINCRISTINE SULFATE
Northwestern University
Phase 3BBB
Irinotecan
EpicentRx, Inc.
Phase 2BBB
Gefetinib
Memorial Sloan Kettering Cancer Center
Phase 2BBB
ETOPOSIDE
NewLink Genetics Corporation
Phase 3BBB

View all 50 →

Same molecule, other indications

Autologous Immunoglobulin Idiotype-Klh Conjugate Vaccine is also rated in:

lymphomaDormant
CCC
Indicative ·
50 / 100
View asset →
lymphoproliferative syndromeDormant
CCC
Indicative ·
50 / 100
View asset →
small intestine cancerDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →